|Atomic Number:||89||Atomic Radius:||260 pm (Van der Waals)|
|Atomic Symbol:||Ac||Melting Point:||1051 °C|
|Atomic Weight:||227||Boiling Point:||3198 °C|
|Electron Configuration:||[Rn]7s26d1||Oxidation States:||3|
From the Greek aktis, aktinos, meaning beam or ray. Discovered by Andre Debierne in 1899 and independently by F. Giesel in 1902. Occurs naturally in association with uranium minerals.
Actinium-227, a decay product of uranium-235, is a beta emitter with a 21.6-year half-life. Its principal decay products are thorium-227 (18.5-day half-life), radium-223 (11.4-day half-life), and a number of short-lived products including radon, bismuth, polonium, and lead isotopes. In equilibrium with its decay products, it is a powerful source of alpha particles. Actinium metal has been prepared by the reduction of actinium fluoride with lithium vapor at about 1100 to 1300-degrees C. The chemical behavior of actinium is similar to that of the rare earths, particularly lanthanum. Purified actinium comes into equilibrium with its decay products at the end of 185 days, and then decays according to its 21.6-year half-life. It is about 150 times as active as radium, making it of value in the production of neutrons.
In April of 2012, Los Alamos National Laboratory announced a new medical isotope project that shows promise for rapidly producing major quantities of a new cancer-treatment agent, actinium 225 (Ac-225). Both a press release and a video are available.